OCT vs OCTA: When to Upgrade Your Practice Equipment

What Standard OCT Measures

Standard spectral-domain OCT (SD-OCT) and swept-source OCT (SS-OCT) measure the reflection of near-infrared light from retinal tissue layers. It builds cross-sectional images of retinal architecture — layer thickness, fluid accumulation, drusen volume, disc morphology. It's excellent at structural imaging: where is the tissue, and how thick is it?

This makes OCT indispensable for managing diseases with structural endpoints: neovascular age-related macular degeneration, diabetic macular edema, retinal vein occlusion, glaucoma progression. If you're managing any of these conditions, OCT is non-negotiable.

What OCTA Adds

OCT angiography (OCTA) uses the same platform as standard OCT but adds a motion-contrast analysis. Instead of measuring light reflection, it compares repeated B-scans at the same location and detects movement — specifically, the movement of red blood cells through vessels. This produces a microvascular map without dye injection.

The clinical difference is significant:

• Diabetic retinopathy: OCTA detects microaneurysms and capillary non-perfusion before visible hemorrhages appear on fundus exam. Early DR is often first evident on OCTA, not clinically.
• Wet AMD: OCTA identifies choroidal neovascularization without fluorescein angiography. For many practices, this eliminates the need for a separate FA visit.
• Glaucoma: OCTA ganglion cell complex analysis can detect vascular changes that precede structural thinning — potentially an earlier indicator of progression.
• Macular telangiectasia: Type 2 MacTel shows characteristic vascular anomalies on OCTA that are difficult to visualize any other way.

The Upgrade Cost Question

OCTA capability typically adds $30,000 to $60,000 to a standard OCT system, depending on the platform and whether you're upgrading an existing unit or purchasing a combined system. A full OCT + OCTA system runs approximately $50,000 to $70,000 total, with some premium platforms at the higher end.

This is real money. The upgrade makes sense when:

• You manage diabetic patients and currently refer out for FA — OCTA would let you image vasculature in-office
• You're actively managing wet AMD and want to reduce referral dependency for CNV monitoring
• Your referral base includes a high proportion of retinal pathology where vascular information changes management
• You want to differentiate your practice with advanced imaging capability as a referral destination

The Equipment Economics

On pure ROI: a typical OCTA scan generates comparable reimbursement to standard OCT (CPT 92134). If you're managing 20-30 diabetic or retinal patients per week who currently need external imaging, capturing that imaging in-house can generate enough procedural revenue to justify the equipment cost within 18-24 months — depending on your patient volume and payer mix.

The additional value is referral retention. When you can say to your retinal specialist, "I have the OCTA here — no need to refer for imaging," you retain the patient relationship and the associated care revenue.

Readiness for OCTA Interpretation

Before upgrading equipment, make sure your practice can interpret what OCTA produces. OCTA images are not intuitively obvious — the vascular layers look different from fluorescein angiography, and there is a learning curve. Poor interpretation means you're not getting the clinical value you're paying for.

Our free OCT course covers OCTA interpretation from the ground up, including the vascular layer anatomy and how to systematically read a scan before you invest in hardware. Start the free course before making the equipment decision — it takes an hour and you'll know where your baseline is.

Our free OCT course covers OCT vs OCTA, vascular layer anatomy, and scan interpretation — structured for ODs upgrading their imaging practice.